BLOOMBERG LAW.COM
U.S. Virus Guidelines Reject Trump-Backed Drug Combination (1)
A panel of medical experts convened by the U.S. National Institutes of Health recommended against the use of a drug combination touted by President Donald Trump for Covid-19 patients. The NIH panel, made up of 50 doctors, pharmacy experts and government researchers and officials, specifically recommended against the use of the anti-malaria drug hydroxychloroquine in combination with the antibiotic azithromycin. The malaria pill can cause heart issues, and the NIH panel warned of the potential for harm from the combination. Trump has repeatedly backed the use of the malaria pill or the combination of drugs on Twitter and at numerous briefings of the Coronavirus Task Force, though some medical experts in his administration have cautioned about the lack of evidence. In a press briefing on April 5th, he said: “What do you have to lose? Take it.” “Although reports have appeared in the medical literature and the lay press claiming successful treatment of patients with Covid-19 with a variety of agents, definitive clinical trial data are needed to identify optimal treatments for this disease,” the NIH panel said in its report, giving broad recommendations for the treatment of Covid-19 patients.
READ MORE AT BLOOMBERGLAW.COM
